SPIOLTO RESPIMAT 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for in Australia - English - Department of Health (Therapeutic Goods Administration)

spiolto respimat 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for in

boehringer ingelheim pty ltd - olodaterol hydrochloride, quantity: 2.736 microgram/actuation (equivalent: olodaterol, qty 2.5 microgram/actuation); tiotropium bromide monohydrate, quantity: 3.124 microgram/actuation (equivalent: tiotropium, qty 2.5 microgram/actuation) - inhalation, conventional - excipient ingredients: purified water; benzalkonium chloride; hydrochloric acid; disodium edetate - spiolto respimat is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

SPIOLTO RESPIMAT 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for inhalation cartridge (with dose indicator) Australia - English - Department of Health (Therapeutic Goods Administration)

spiolto respimat 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for inhalation cartridge (with dose indicator)

boehringer ingelheim pty ltd - olodaterol hydrochloride, quantity: 2.736 microgram/actuation (equivalent: olodaterol, qty 2.5 microgram/actuation); tiotropium bromide monohydrate, quantity: 3.124 microgram/actuation (equivalent: tiotropium, qty 2.5 microgram/actuation) - inhalation, conventional - excipient ingredients: purified water; benzalkonium chloride; hydrochloric acid; disodium edetate - spiolto respimat is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

YANIMO RESPIMAT 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for inh Australia - English - Department of Health (Therapeutic Goods Administration)

yanimo respimat 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for inh

boehringer ingelheim pty ltd - olodaterol hydrochloride, quantity: 2.736 microgram/actuation (equivalent: olodaterol, qty 2.5 microgram/actuation); tiotropium bromide monohydrate, quantity: 3.124 microgram/actuation (equivalent: tiotropium, qty 2.5 microgram/actuation) - inhalation, conventional - excipient ingredients: purified water; benzalkonium chloride; hydrochloric acid; disodium edetate - yanimo respimat is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

Spiolto Respimat 2.5 microgram/2.5 microgram, inhalation solution United Kingdom - English - myHealthbox

spiolto respimat 2.5 microgram/2.5 microgram, inhalation solution

boehringer ingelheim international gmbh - tiotropium (as bromide monohydrate), olodaterol (as hydrochloride) - inhalation solution - 2.5 microgram/2.5 microgram per puff - drugs for obstructive airway diseases, adrenergics in combination with anticholinergics - it is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd)

YANIMO RESPIMAT 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for inhalation cartridge (with dose indicator) Australia - English - Department of Health (Therapeutic Goods Administration)

yanimo respimat 2.5 micrograms/2.5 micrograms tiotropium (as bromide monohydrate)/olodaterol (as hydrochloride) solution for inhalation cartridge (with dose indicator)

boehringer ingelheim pty ltd - olodaterol hydrochloride, quantity: 2.736 microgram/actuation (equivalent: olodaterol, qty 2.5 microgram/actuation); tiotropium bromide monohydrate, quantity: 3.124 microgram/actuation (equivalent: tiotropium, qty 2.5 microgram/actuation) - inhalation, conventional - excipient ingredients: purified water; benzalkonium chloride; hydrochloric acid; disodium edetate - yanimo respimat is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

SPIOLTO RESPIMAT Israel - English - Ministry of Health

spiolto respimat

boehringer ingelheim israel ltd. - olodaterol as hydrochloride; tiotropium bromide as monohydrate - solution for inhalation - olodaterol as hydrochloride 2.5 mcg; tiotropium bromide as monohydrate 2.5 mcg - vilanterol and umeclidinium bromide - spiolto respimat is indicated as a maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).

Spiolto Respimat Inhalation Solution 2.5mcg2.5mcg per actuation Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

spiolto respimat inhalation solution 2.5mcg2.5mcg per actuation

boehringer ingelheim (malaysia) sdn. bhd. - tiotropium bromide monohydrate; olodaterol hydrochloride -

INSPIOLTO RESPIMAT SOLUTION Canada - English - Health Canada

inspiolto respimat solution

boehringer ingelheim (canada) ltd ltee - tiotropium (tiotropium bromide monohydrate); olodaterol (olodaterol hydrochloride) - solution - 2.5mcg; 2.5mcg - tiotropium (tiotropium bromide monohydrate) 2.5mcg; olodaterol (olodaterol hydrochloride) 2.5mcg - antimuscarinics antispasmodics

Spiolto Respimat New Zealand - English - Medsafe (Medicines Safety Authority)

spiolto respimat

boehringer ingelheim (nz) ltd - olodaterol hydrochloride 0.0248%{relative} equivalent to to olodaterol 2.5mcg per actuation; tiotropium bromide monohydrate 0.0283%{relative} equivalent to to tiotropium 2.5mcg per actuation - solution for inhalation - 2.5mcg/2.5mcg - active: olodaterol hydrochloride 0.0248%{relative} equivalent to to olodaterol 2.5mcg per actuation tiotropium bromide monohydrate 0.0283%{relative} equivalent to to tiotropium 2.5mcg per actuation excipient: benzalkonium chloride disodium edetate hydrochloric acid purified water - spiolto respimat is indicated for the long term, once daily maintenance treatment in patients with copd (including chronic bronchitis and emphysema), to reduce airflow obstruction, to improve quality of life, and to reduce associated dyspnoea.

STIOLTO RESPIMAT- tiotropium bromide and olodaterol spray, metered United States - English - NLM (National Library of Medicine)

stiolto respimat- tiotropium bromide and olodaterol spray, metered

boehringer ingelheim pharmaceuticals inc. - tiotropium bromide monohydrate (unii: l64sxo195n) (tiotropium - unii:0eb439235f), olodaterol hydrochloride (unii: 65r445w3v9) (olodaterol - unii:vd2ysn1afd) - tiotropium 3.124 ug - stiolto respimat is a combination of tiotropium and olodaterol indicated for long-term, once-daily maintenance treatment of patients with chronic obstructive pulmonary disease (copd), including chronic bronchitis and/or emphysema. important limitations of use - stiolto respimat is not indicated to treat acute deteriorations of copd [see warnings and precautions (5.2)]. - stiolto respimat is not indicated to treat asthma. the safety and effectiveness of stiolto respimat in asthma have not been established. use of a laba, including stiolto respimat, without an inhaled corticosteroid is contraindicated in patients with asthma [see warnings and precautions (5.1)] . stiolto respimat is not indicated for the treatment of asthma. stiolto respimat is contraindicated in patients with a hypersensitivity to tiotropium, ipratropium, olodaterol, or any component of this product [see warnings and precautions (5.4)] . in clinical trials and postmarketing experience with tiotropium, immediate hypersensitivity reactions, inc